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A B S T R A C T
Ovine Eimeria spp. infections cause reduced welfare, increased mortality, and substantial economic losses, and
anticoccidials are crucial for their control. Recent reports of toltrazuril resistance in pigs, and anecdotal reports
of reduced anticoccidial eﬃcacy in lambs, necessitate evaluation of anticoccidial eﬃcacy. Due to the substantial
lifecycle diﬀerences between nematodes and coccidia, current WAAVP methods for assessing anthelmintic ef-
ﬁcacy are not suitable for such evaluations. Faecal samples were collected from 8 pairs of twin lambs from 36
Norwegian sheep farms 6–8 days after turnout. One twin of each pair was then treated with 20mg/kg toltrazuril
and a second faecal sample from all lambs was collected 7–11 days later. Oocyst excretion rate in all samples was
determined using McMasters. Suitability of treatment timing was investigated by evaluating the increase in mean
log oocyst excretion in untreated lambs. Based on comparisons between groups, a threshold of≥0.75 (13 farms)
was used to identify farms where drug eﬃcacy could be assessed with conﬁdence, drug eﬃcacy on farms with
increases of ≥0.5 but< 0.75 (7 farms) were evaluated with caution, and drug eﬃcacy on farms with increases
of< 0.5 (16 farms) was not estimated. Reduction in oocyst excretion between samples from treated lambs
compared with controls from the 20 farms with a threshold of ≥0.5 were then analysed using a generalised
linear mixed model. The results were classiﬁed based on 95% CI obtained using parametric bootstrapping.
Among these 20 farms, two exhibited reduced drug eﬃcacy (upper 95% CI < 95%), 13 had good eﬃcacy
(lower 95% CI > 90%), and for 5 the results were inconclusive. This is the ﬁrst evidence-based report of re-
duced anticoccidial eﬃcacy in ovine Eimeria spp. Additionally, we highlight the problem of sub-optimal timing
of treatment (16/36 farms), which could potentially result in incorrect conclusions being reached regarding lack
of drug eﬃcacy.
1. Introduction
Eimeria spp. are host-speciﬁc obligate intracellular protozoan para-
sites that infect ﬁsh, reptiles, birds and mammals (Walker et al., 2013).
Of the 15 Eimeria spp. known to infect sheep, only two are regarded as
major pathogens: E. ovinoidalis and E. crandallis (Catchpole et al., 1976;
Catchpole and Gregory, 1985; Rommel, 2000; Joachim et al., 2018). E.
ahsata, and occasionally E. bakuensis, are generally considered to be
minor pathogens, which may cause clinical signs in heavily infected
animals (Mahrt and Sherrick, 1965; Deplazes et al., 2016). In addition,
infections with multiple species might also be important for the de-
velopment of clinical signs, as described for calves (Enemark et al.,
2013). Coccidiosis in lambs caused by pathogenic Eimeria spp. leads to
reduced welfare, increased mortality and substantial economic losses in
the sheep industry worldwide (Foreyt, 1990; Chartier and Paraud,
2012).
Pasture management and hygienic measures, e.g., cleaning water
troughs and maintaining dry bedding, are considered important factors
for reducing the infection pressure from Eimeria spp. (Taylor, 2000;
Daugschies and Najdrowski, 2005). However, these measures are often
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labour intensive and can be diﬃcult to implement, and chemopro-
phylaxis with anticoccidials is therefore frequently used, in addition to
hygiene measures for control of clinical coccidiosis in sheep farms
(Taylor and Kenny, 1988; Platzer et al., 2005; Saratsis et al., 2013;
Odden et al., 2017). Metaphylactic administration of a single oral
treatment with toltrazuril in the prepatent period has been shown to be
eﬀective at reducing clinical signs and maintaining adequate growth
rates in diﬀerent production systems (Gjerde and Helle, 1986, 1991;
Taylor and Kenny, 1988; Le Sueur et al., 2009; Saratsis et al., 2013). In
several European countries (e.g., Denmark, Sweden, and Norway) tol-
trazuril is the only anticoccidial available for use in sheep
(Felleskatalogen, 2017; Läkemedelsverket, 2017; Veterinærmedicinsk
Industriforening, 2017). In other countries, other treatments such as
diclazuril and decoquinate are also available (Taylor, 2000; Diaferia
et al., 2013). According to the Veterinary Medicines Directorate,
510,388 kg and 787,300 kg toltrazuril from products authorised for use
in farm animals were sold in the UK in 2014 and 2015, respectively (Dr
Gillian Diesel, Head of the Pharmacovigilance Team, personal com-
munication). However, treatment of clinical coccidiosis is considered to
be ineﬃcient due to the extensive intestinal damage caused by the
parasite (Mundt et al., 2003; Taylor et al., 2003).
Anticoccidial resistance (ACR) is a widely recognised problem in
poultry production (Chapman, 1997; Stephan et al., 1997; Chapman
and Jeﬀers, 2014; Lan et al., 2017), and has been reported for mon-
ensin, salinomycin, nicarbazin, halofuginone, robenidine, toltrazuril
and diclazuril (McDougald, 1981; Chapman, 1997; Stephan et al.,
1997). ACR in poultry production is generally considered to be the
result of intensive use of anticoccidials, which has led to loss of sensi-
tivity to these drugs (Peek and Landman, 2011). Testing for antic-
occidial eﬃcacy (ACE) in poultry production involves the use of his-
topathological observations and the combination of diﬀerent indexes,
such as oocyst index, body weight gain, relative weight gain, lesion
scores, and anticoccidial index (Chapman, 1998). However, no such
methods have been published for the evaluation of anticoccidial eﬃ-
cacy in other livestock, including sheep. One obvious practical re-
quirement for a method to be useful in ﬁeld situations is that it should
not include euthanasia of large numbers of animals.
The controlled eﬃcacy test (CET) is the gold standard method for
the evaluation of anthelmintic eﬃcacy (Wood et al., 1995; Coles et al.,
2006). The CET is performed by infecting animals with a suspected
resistant isolate, treating the animals with the drug under evaluation,
and then euthanizing the animals before quantifying the parasite
burden post mortem. This procedure has various diﬃculties for im-
plementation, not only because of the ethical concerns associated with
euthanasia of the animals, but also due to the requirement for a para-
site-free environment in testing the suspected strain (Taylor et al.,
1995; Wood et al., 1995). Similar problems relate to the assessment of
anticoccidial eﬃcacy against Eimeria spp. in poultry (Chapman, 1998)
and Cytosisospora suis in pigs (Shrestha et al., 2017). Thus, evaluation of
anthelmintic eﬃcacy in animals is routinely assessed by the faecal egg
count reduction test (FECRT), currently recommended by the World
Association for the Advancement of Veterinary Parasitology (WAAVP),
and involves comparison of faecal egg counts pre- and post-treatment
(Coles et al., 1992). The advantage of the FECRT is its ability to assess a
range of drugs under ﬁeld conditions. However, analysis of the results
for FECRTs can be diﬃcult in cases where egg excretion rate is low,
where the sensitivity of the counting methods is poor, for highly ag-
gregated faecal egg counts, and when the sample size is small
(Torgerson et al., 2005; Denwood et al., 2010; Dobson et al., 2012;
Peña-Espinoza et al., 2014).
Diﬀerent statistical models have been applied to improve the cal-
culation of the estimated eﬃcacy from FECRT results, including boot-
strapping techniques, and Bayesian methods such as Markov chain
Monte Carlo (Denwood et al., 2010; Torgerson et al., 2014; Peña-
Espinoza et al., 2016). However, challenges remain regarding the use of
faecal oocyst count reduction tests (FOCRT), the (coccidial) oocyst
equivalent of FECRT, for the assessment of ACE, due to extreme var-
iation in oocyst excretion rates compared with excretion of helminth
eggs. This is, in general, a reﬂection of the more complicated biology
and lifecycle of Eimeria spp., in which sexual reproduction of the
parasite in the animal host is preceded by several rounds of intracellular
asexual reproduction that occurs in waves (Walker et al., 2013). The
maximum range of Eimeria oocyst excretion can diﬀer from between 0
and 75,000 to between 0 and 2,000,000 oocyst per gram (OPG), with
large inter-individual variation (Chapman, 1974). In contrast, helminth
egg excretion usually does not exceed 20,000 eggs per gram (Sréter
et al., 1994; Zaros et al., 2014). As toltrazuril acts against intracellular
stages of the parasite, and extracellular stages are unaﬀected
(Haberkorn and Stoltefuss, 1987; Harder and Haberkorn, 1989;
Mehlhorn, 2008), oocyst counts immediately post treatment may not be
zero. Detailed data concerning the eﬃcacy of toltrazuril when the drug
was ﬁrst marketed are not available from the literature, but practical
experience conﬁrms that post-treatment oocyst counts are not always
zero even when the observed clinical eﬃcacy is good. Thus, any model
for evaluation of ACE has to take into account that a reduction to zero is
not always the case, even when highly eﬃcacious anticoccidials are
used (Taylor and Kenny, 1988; Gjerde and Helle, 1991).
The emergence of ACR in poultry and pig production systems (Lan
et al., 2017; Shrestha et al., 2017), along with anecdotal reports of
reduced ACE in Norwegian lambs (Odden et al., 2017), demonstrates
the need for a FECRT-type method to evaluate drug eﬃcacy in live
animals. However, due to the reasons outlined above, the standard
FECRT (Coles et al., 1992) currently recommended by WAAVP for
evaluation of anthelmintic eﬃcacy is unsuitable for use with coccidia.
The aim of our study was therefore to develop a tool for ﬁeld evaluation
of ACE, based on oocyst counts in lambs, and use it in a preliminary
investigation of ACE in Norwegian sheep farms.
2. Materials and methods
2.1. Study design
2.1.1. Inclusion criteria
Norwegian sheep farms (n=80) were selected based on a previous
questionnaire study performed in October 2015 (Odden et al., 2017).
The inclusion criteria were: a) treatment with anticoccidials annually
for at least four years, b) coccidiosis-related symptoms in lambs treated
with an anticoccidial, and c) ﬂock size of more than 60 winter-fed ewes.
The geographical location of the farms was consistent with the popu-
lation density of sheep farms in Norway (Supplementary data 1)
(Statistics Norway, 2017). All 80 farmers, of whom 60 agreed to par-
ticipate, were contacted via telephone during the winter of 2016. The
60 participating farmers received a detailed written sampling and
treatment protocol, a 10ml syringe for oral drenching, envelopes with
pre-paid postage, and a “faecal spoon” to facilitate sampling of young
lambs (Supplementary data 2). Farms with< 5 lambs per treatment
group were excluded.
2.1.2. Timing of treatment and sampling
Most Norwegian ewes are winter housed, with indoor lambing in
the spring i.e. March–May (Vatn, 2009). Turnout to spring pastures
commonly occurs two to three weeks postpartum (Domke et al., 2011).
Clinical signs due to coccidiosis are mainly seen at around turnout.
Lambs may become infected before turnout, mainly due to oocyst ex-
cretion from older, already infected lambs (Taylor, 1995), or im-
mediately after turnout, as the oocysts survive overwintering on per-
manent pastures (Helle, 1970; Gjerde and Helle, 1991). Current
Norwegian recommendations against ovine coccidiosis consist of a
single metaphylactic treatment with toltrazuril, either at turnout or
around one week after turnout (Animalia, 2017).
Farmers enrolled in the study were instructed to identify 8 pairs of
twin lambs from which they would twice collect faecal samples during
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the 2016 spring grazing season. Age at turnout was ≥14 days for all
lambs included in the study. Sample 1 was taken 6–8 days after turnout
(Fig. 1). The aims were: 1) to have a common sampling protocol for all
lambs, regardless of whether they became infected indoors or after
turnout, and 2) to collect the ﬁrst sample while oocyst excretion was
either below the limit of detection, or low. At the same time as col-
lection of the ﬁrst sample, the lamb with the lowest ear tag number
from each twin pair was treated with 20mg/kg toltrazuril (Baycox®
Sheep vet, Bayer Animal Health). Farmers were encouraged to weigh
the lambs prior to treatment. Sample 2 was collected from the same
animals 7–11 days after Sample 1; that is, before any oocysts ingested
post-treatment could have resulted in additional oocyst excretion. All
faecal samples were collected per rectum from individual lambs using a
“faecal spoon”.
2.1.3. Evaluation of faecal samples
The faecal consistency was scored on a scale from one to ﬁve (Holm
et al., 2014). The faecal samples were stored for a maximum of 7 days
at 4 °C and the rate of oocyst excretion was determined using a modiﬁed
McMaster technique with a theoretical sensitivity of 5 oocysts per gram
(OPG). Brieﬂy, water was added to 1–4 g of faeces, which was homo-
genised, ﬁltered, concentrated by centrifugation and mixed with ﬂo-
tation ﬂuid (saturated sodium chloride with glucose; density: 1.27 g/
ml; sample/ﬂotation ﬂuid ratio: 1:1 to 1:2 depending on volume of
sediment). A subsample (0.6 ml) was then transferred to a disposable
counting chamber ﬁtted with a thin coverglass, which facilitated de-
tection, and the oocysts were enumerated at 200/400× magniﬁcation.
In samples with few oocysts (OPG < 10,000) the whole chamber was
evaluated, whereas one row (≈1/20) or three ﬁelds of vision (≈1/200)
of the chamber was counted in samples with higher numbers of oocysts
(Henriksen and Aagaard, 1976; Henriksen and Korsholm, 1984). One
hundred Eimeria oocysts from all samples with OPG ≥1000 were ex-
amined by light microscopy at 400× magniﬁcation. The oocysts were
identiﬁed to species level without sporulation, using morphological
criteria (Eckert et al., 1995).
2.2. Evaluation of anticoccidial eﬃcacy
2.2.1. Statistical justiﬁcation
Previously published observations of oocyst excretion in lambs have
shown that excretion follows an exponential pattern initially, followed
by a plateau phase (Chapman, 1974; Gregory et al., 1989). This implies
that the logarithm of the expectation of oocyst excretion increases
linearly during the initial phase, followed by a reduction in the rate of
increase during the subsequent plateau phase (Fig. 2). This known re-
lationship has the useful feature that an anticoccidial intervention at
any time point has no eﬀect on the slope of the linear relationship with
time, so that anticoccidial eﬃcacy can be calculated as the absolute
diﬀerence in log expectation of oocyst count at any point during the
exponential growth phase. However, this assumes that parasite re-
plication also follows an exponential rise between the time of treatment
and the time of oocyst quantiﬁcation, and therefore that the plateau
phase of oocyst excretion has not yet been reached. Thus, three con-
ditions must be satisﬁed regarding timing of anticoccidial treatment
and FOCRT quantiﬁcation:
1. Treatment must be given after the initial infection of the lambs.
2. A minimum time must be allowed between treatment and FOCRT to
allow a reduction in oocyst shedding to become detectable.
3. Both treatment and the FOCRT must be performed during the phase
of exponential rise in excretion.
Additionally, although not a strict requirement for the procedure to
be valid, greater statistical conﬁdence will be obtained in the mean
count estimates, and therefore FOCRT percentage, if the mean oocyst
counts are relatively high (Denwood et al., 2012). Therefore, the the-
oretical optimal time for the FOCRT (Sample 2) to be conducted, from a
statistical point of view, is as close as possible to the end of the phase of
exponential rise in excretion. We note that this statistical consideration
is somewhat at odds with the optimal time point for most eﬀective
control of the parasite, for which an earlier treatment is likely to be
preferable.
2.2.2. Identifying the phase of exponential rise in excretion rate
There are currently no guidelines for identifying when oocyst ex-
cretion in the ﬁeld is in the phase of exponential increase. We therefore
followed a simple heuristic, based on oocyst counts derived from the
untreated control animals at the time of the pre-treatment and post-
treatment sampling. This heuristic assumes that the dynamics of para-
site replication during the exponential phase are similar between farms,
which is a substantially simplifying assumption, given that there are
multiple species of Eimeria with diﬀerent cycle parameters within the
host animal, and that diﬀerent farms may have diﬀerent species.
The heuristic used was as follows. Firstly, a crude estimation of the
linear eﬀect of days between oocyst observations on the mean of the
logarithmically transformed oocyst counts in the untreated animals at
each farm was made (referred to as the “slope”). For this procedure, a
ﬁxed constant of 1 was added to all data before transformation to avoid
numerical problems with observations of zero. Secondly, the results for
all farms were compared graphically in order to identify a qualitatively
appropriate threshold above which the estimated slopes were sub-
jectively judged to be consistent with those obtained from farms with
the greatest change in mean log faecal oocyst count (FOC), and there-
fore assumed to be representing the exponential phase. A second, lower
threshold was also identiﬁed above which the slopes were deemed to be
only moderately consistent with those obtained from farms with the
greatest change in FOC. Data from farms for which the lower threshold
for slope was not met were not included in the analyses due to the
apparently poor timing of sampling and treatment.
2.2.3. Analysis of faecal oocyst count reduction
The farms for which the data from the control animals were judged
to indicate sampling had been performed during the exponential phase
were analysed for faecal oocyst count reduction (FOCR) using a gen-
eralised linear mixed model, implemented using the lme4 package
(Bates et al., 2015) for R (R Core Team, 2017). Only the post-treatment
counts from treated and control animals were used for evaluation of
eﬃcacy due to the theoretical justiﬁcation of the linear increase in log
FOC given in section 2.2.1, as well as empirical evidence for a lack of
relationship between the pre-treatment mean and these eﬃcacy esti-
mates (data not shown). A Poisson distribution with log link was used
as the response distribution for the number of oocysts, using an oﬀset
within the model to take into account the dilution factor applied during
counting of each sample. Random eﬀects of observation and twin pair
were used to describe the extra-Poisson variation (over dispersion)
Fig. 1. Study design. Twin lambs (n=16 per farm) from 36 Norwegian farms
with signs of coccidiosis in previous grazing seasons were included in the study.
The treatment group was treated with toltrazuril (20mg/kg) whereas the
control group was left untreated. Oocyst counts were based on McMaster
analysis.
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within the data, and all farms were analysed separately. Conﬁdence
intervals (CIs) for the geometric mean FOCR were obtained using
parametric bootstrapping with 500 iterations. The FOCRT results then
enabled classiﬁcation of ACE at the farm level, based on 95% CI, as
“good eﬃcacy” (lower 95% CI > 90%), “reduced eﬃcacy” (upper 95%
CI < 95%), or inconclusive (neither of the above is true), based on
equivalent classiﬁcations for arithmetic mean reductions as previously
used by Geurden et al. (2015) and Peña-Espinoza et al. (2016) in in-
vestigations of anthelmintic eﬃciency.
3. Results
3.1. Identifying the exponential growth phase
Of the 60 farms that initially agreed to participate in the study, 49
completed the sampling. However, 13 farms were excluded due to lack
of compliance with the sampling protocol, leaving 36 farms for which
the increase in mean log OPG could be assessed in the control animals.
Based on these estimates, along with the assumption that the parasite
dynamics (and therefore exponential rate of increase) should be similar
between farms for which sampling was during the exponential phase
(see comments regarding this assumption in section 2.2.2), a threshold
of approximately 0.75 was identiﬁed. Above this threshold, the abso-
lute increase in mean log OPG in untreated lambs seemed to be suﬃ-
ciently consistent for us to be conﬁdent that both treatment and sam-
pling were conducted at appropriate time points for the analyses
(Fig. 3). A further threshold of 0.5, was identiﬁed above which the
timing is broadly consistent with the required increase in OPG in un-
treated lambs, but also where the possibility of sub-optimal timing
cannot be excluded. Farms for which the increase in control lambs was
below 0.5 were deemed to represent farms where the timing of sam-
pling and treatment were not during the phase of exponential increase.
Based on these criteria, 13 farms were considered to have been sampled
at the appropriate time for our purposes and could therefore provide a
useful estimate of drug eﬃcacy, and 7 farms were deemed to have
possibly been sampled at a suboptimal time and could therefore yield a
drug eﬃcacy estimate that should be analysed with caution. The data
from the remaining 16 farms were considered unsuitable for further
analysis as treatment and/or sampling were not during the exponential
phase of oocyst excretion.
3.2. Assessment of eﬃcacy
The 20 farms for which treatment and sampling were deemed to
have either been consistent with, or broadly consistent with, appro-
priate timing were then analysed for ACE. Of the 13 farms classiﬁed
with conﬁdence, 7 were found to have good ACE, 4 were inconclusive,
and 2 had reduced treatment eﬃcacy (Table 1). Of the 7 farms classi-
ﬁed with caution, 6 had good ACE and 1 was inconclusive. Mean and
median OPG from all the 36 farms complying with the sampling pro-
tocol can be found in Table 2, and the oocyst counts from all included
lambs can be found in Supplementary data 3.
Of the 20 farms included in the assessment of drug eﬃcacy, lamb
weights at treatment were submitted for 16 farms (Table 1). The post-
treatment composition of Eimeria spp. in treated lambs from the farms
where reduced eﬃcacy was detected was: 73.7% E. faurei, 15.5% E.
ovinoidalis, and 10.8% other Eimeria spp. (farm 10), and 39.1% E. parva,
35.4% E. ovinoidalis, and 25.5% other Eimeria spp. (farm 22).
4. Discussion
Appropriate ﬁeld tests are necessary in order to determine ACE and
to detect potential resistance to treatment among ovine Eimeria isolates.
However, suitable approaches for identifying ACR in farmed ruminants
have not previously been developed (Joachim et al., 2018). The current
work presents one approach for ﬁeld evaluation of ACE against ovine
Eimeria spp. using a method based on the WAAVP recommended FECRT
for identifying resistance to anthelmintics (Coles et al., 1992), but
modiﬁed to enable evaluation of drug eﬃcacy against Eimeria spp., or
resistance of Eimeria spp. against speciﬁc treatments.
One important ﬁnding of our study was that timing of anticoccidial
treatment was often sub-optimal, being detected in 16 of 36 farms. Such
timing could potentially result in false conclusions regarding lack of
drug eﬃcacy, as well as not providing optimal protection against
clinical coccidiosis for the individual lambs.
A second important ﬁnding was an apparent reduction in the eﬃ-
cacy of toltrazuril against Eimeria spp., including the pathogenic E.
ovinoidalis, in 2 of 20 farms for which treatment and sampling time was
appropriate. It should be noted that inclusion criteria for the study in-
cluded ﬂock size, continuous use of anticoccidials for several years, and
occurrence of previous episodes of diarrhoea. These are all factors that
are recognised as being correlated with increased risk of ACR in poultry
(Chapman et al., 2010; Peek and Landman, 2011; Lan et al., 2017).
Thus, these “potential ACR farms” are not representative of Norwegian
sheep farms, and further studies are needed to establish the true pre-
valence of ACR in Norway. However, due to the widespread depen-
dence of sheep farmers on chemoprophylaxis to control ovine cocci-
diosis, the emergence of reduced eﬃcacy of toltrazuril indicated here
may have severe consequences for the sheep industry, particularly in
Northern Europe, due to the limited treatment alternatives
(Felleskatalogen, 2017; Läkemedelsverket, 2017; Veterinærmedicinsk
Industriforening, 2017).
The main objectives of anticoccidial treatment are: 1) to decrease
oocyst excretion, 2) to reduce the severity of clinical signs, and 3) to
Fig. 2. Graphical illustration of the theoretical re-
lationship between an exponentially increasing true
parasite burden on the exponent scale (left) and the
log of the same quantity (right) over time. A pro-
portional reduction in the simulated ‘treated’ (blue)
mean occurring 1/10 into the time span results in the
log of the two quantities increasing in parallel during
the exponential phase of the control mean (red). This
exponential phase ends around 6/10 into the time
span, after which a plateau can be seen on the ex-
ponent scale and the lines cease to be parallel on the
log scale. (For interpretation of the references to
colour in this ﬁgure legend, the reader is referred to
the Web version of this article.)
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allow development of protective immunity (Taylor et al., 2011). Me-
taphylactic treatment (i.e., treatment administered during the pre-
patent period before oocyst excretion can be detected and prior to de-
velopment of clinical signs) is therefore preferable. Due to the
exponential oocyst excretion curve (Chapman, 1974; Gregory et al.,
1989), the eﬀect of treatment can only be assessed during the ex-
ponential growth phase of the parasite, which necessitates inclusion of
both pre-treatment samples and untreated controls in the analyses.
Identiﬁcation of this growth phase in our study was based on evaluation
of the “slope” (change in mean log OPG per day in the controls) for each
farm that was used to determine if drug eﬃcacy could be interpreted
with conﬁdence. However, this evaluation was based on thresholds
chosen somewhat arbitrarily due to characteristics of our dataset, and
may require adjustment following acquisition of data from more farms
in future studies. Timing of treatment, and also timing of the FOCRT
itself, which is supposed to be approximately one-week post-treatment,
is thus a major challenge and should be based on knowledge of previous
outbreaks of coccidiosis and farm management factors, such as duration
of the lambing season, time of turnout, grazing conditions (± perma-
nent pasture), and weather conditions. Historically, treatment practices
in Norway relied on the assumption that lambs were infected after
turnout, with the development of clinical symptoms 2–3 weeks later
(Helle, 1970; Gjerde and Helle, 1986). However, results from the pre-
sent study indicate that lambs in some farms are infected with Eimeria
spp. shortly after lambing, while they are still housed indoors. This
seems to be common, particularly in cases where turnout is delayed due
to adverse weather conditions (unpublished results from our group).
For the present study, we standardised the sampling protocol based on
general knowledge of management procedures and treatment routines
in Norwegian sheep farms (Odden et al., 2017). However, sampling
based on speciﬁc knowledge of transmission dynamics in the individual
farms would most likely have helped for at least some of the 44% of
farms for which treatment timing was sub-optimal.
Another factor that is known to be associated with accelerating the
development of drug resistance is under-dosing with the drug (Smith
et al., 1999; Wolstenholme et al., 2004). In our study, the farmers were
responsible for treating their animals with the correct dosage. The
Fig. 3. Identiﬁcation of the exponential growth phase of the oocyst excretion. Graphs illustrate the slope between the mean log OPG and time (pre- and post-
treatment samples) for the control lambs in the 36 farms complying with the sampling protocol. Classiﬁcation was performed with conﬁdence in farms with a slope
of≥0.75 (green), and with caution if the slope was≥0.5 and < 0.75 (blue). Data from farms for which these thresholds were not met were deemed unclassiﬁable
due to the poor timing of sampling (red). The number at the bottom right of each panel indicates the estimated slope for the given ﬂock (panel title). (For
interpretation of the references to colour in this ﬁgure legend, the reader is referred to the Web version of this article.)
Table 1
Maximum likelihood estimates and 95% conﬁdence intervals (CI) for the geo-
metric mean eﬃcacy based on post-treatment oocyst counts for the 20 classi-
ﬁable sheep farms. The slope gives the change in mean log OPG per day in the
controls, and was used to determine if drug eﬃcacy could be calculated: 13 of
the ﬂocks could be evaluated with conﬁdence (slope≥0.75) and 7 of the ﬂocks
were evaluated with caution (0.5≤ slope < 0.75).









10a 8 8 0.96 37.8 −58.3 73.3 Reduced
eﬃcacy
22a 8 8 0.75 81.7 53.1 94.0 Reduced
eﬃcacy
35a 7 7 0.90 56.0 −433.9 96.6 Inconclusive
16a 7 6 0.91 81.3 −103.8 98.9 Inconclusive
6a 7 8 1.09 96.0 72.7 99.3 Inconclusive
28a 6 6 0.87 95.4 86.5 98.4 Inconclusive
8 8 8 0.84 100.0 99.7 100.0 Eﬃcacious
3 8 8 0.94 99.3 95.0 99.9 Eﬃcacious
17a 6 8 1.03 99.3 93.6 99.9 Eﬃcacious
2 8 8 1.18 99.5 96.8 99.9 Eﬃcacious
25a 7 7 1.00 99.5 96.6 99.9 Eﬃcacious
24a 7 8 0.97 99.8 98.6 100.0 Eﬃcacious
36a 8 8 0.86 99.8 98.4 100.0 Eﬃcacious
9a 8 8 0.50 97.6 16.5 100.0 Caution:
inconclusive
13a 8 8 0.63 100.0 100.0 100.0 Caution:
eﬃcacious
26a 8 8 0.71 100.0 100.0 100.0 Caution:
eﬃcacious
7 8 8 0.54 99.4 97.3 99.8 Caution:
eﬃcacious
12a 8 8 0.74 99.5 96.4 99.9 Caution:
eﬃcacious
32a 8 8 0.53 99.8 99.2 100.0 Caution:
eﬃcacious
18a 6 6 0.55 99.9 99.0 100.0 Caution:
eﬃcacious
a Farms from which body weights at treatment were available.
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farmers were encouraged to weigh their lambs prior to treatment, and a
dosage table and a syringe were provided to enable accurate dosages
being used. Although the accuracy of dosing was not investigated,
lambs from all farms where reduced eﬃcacy or inconclusive results
were found had been weighed prior to treatment. Therefore, although
under-dosing cannot be excluded, it does not seem to be a likely cause
of the reduced drug eﬃcacy.
There has been extensive discussion of the statistical aspects of in-
terpreting the data from FECRT, including the relative merits of ar-
ithmetic and geometric means. Miller et al. (2006) concluded that the
results of a FECRT based on an arithmetic mean reduction in egg counts
can be inconsistent, whereas Dobson et al. (2009) suggested that ar-
ithmetic means provide better estimates of parasite egg output than
geometric means. However, the situation regarding the data from Ei-
meria FOCRT is quite diﬀerent to that for nematode FECRT in that the
distribution of oocyst counts is typically far more skewed than that of
egg counts, with occasional extremely high oocyst count observations.
This is partially a reﬂection of the multiple rounds of intracellular
asexual reproduction in the Eimeria lifecycle, and that do not occur with
nematodes. In this situation of highly over-dispersed parasite popula-
tions with inconsistent variation, the geometric mean is a more ap-
propriate estimator of the central tendency parameter (Smothers et al.,
1999). More fundamentally, the statistical justiﬁcation presented in
section 2.2.1 suggests that considering the change in arithmetic mean of
the data on the log scale is the most appropriate course of action, and
this is equivalent to considering the change in geometric mean on the
exponent scale. We therefore believe that considering the geometric
mean reduction for treated animals is most appropriate. This also fa-
cilitates the use of a more standard frequentist modelling approach
using an over-dispersed Poisson distribution with log link and ﬁxed
eﬀect of time interval to estimate the change in geometric mean count,
with CIs generated using a relatively standard parametric bootstrapping
procedure.
Other widely discussed statistical aspects of interpreting data from
FECRT relate to the sample size and the sensitivity of the laboratory
method. The sensitivity of commonly used McMaster methods for per-
forming Eimeria oocyst counts usually range between 5 and 50 OPG
(Reeg et al., 2005; Saratsis et al., 2011). The method used in our study
has a theoretical sensitivity of 5 OPG, which, given the extremely high
mean OPG values, is of suﬃcient sensitivity to ensure the oocyst count
values will be high enough to minimise the proportion of false/excess
zeros that may otherwise aﬀect the distribution of counts and bias the
ﬁnal results (Denwood et al., 2008; Love et al., 2017). In FECRT-cal-
culations, diagnostic accuracy can be improved by increasing the
sample size and lowering the detection limit (Levecke et al., 2012).
Coles et al. (1992) suggested a minimum sample size of 15 animals per
treatment group. In the present study, the sample size of 8 lambs per
treatment group was chosen as a pragmatic compromise between the
statistical importance of a large sample size and the number of lambs
that we expected the farmers to be able to sample twice. However,
based on the relatively large proportion of farms that were classiﬁed as
inconclusive, we recommend that this sample size should be increased
Table 2
Oocyst counts pre- and post-treatment in toltrazuril treated lambs and untreated controls from the 36 farms complying with the sampling protocol. Arithmetic mean:
A-mean; geometric mean: G-mean and median oocysts per gram (OPG).
Farm Sample 1 Sample 2
Treated Control Treated Control
A-mean G-mean Median A-mean G-mean Median A-mean G-mean Median A-mean G-mean Median
1 1691.9 454.5 665.0 3993.1 998.6 2795.0 742.5 96.8 65.0 20373.1 4269.1 4840.0
2 5.6 12.3 0.0 175.0 220.3 0.0 31719.4 2289.1 1537.5 796962.5 434112.9 649500.0
3 6903.1 874.3 0.0 6.3 25.0 0.0 3545.0 347.6 217.5 120957.5 28274.0 38600.0
4 1178.8 580.5 20.0 33903.1 12810.4 1712.5 979.4 715.3 360.0 34691.3 4998.2 15850.0
5 40000.0 240000.0 0.0 9.5 13.8 2.5 23031.7 736.6 105.0 140.8 69.6 17.5
6 78461.4 11530.7 0.0 8.8 10.8 5.0 63010.6 10770.7 19050.0 394271.4 268180.9 364000.0
7 6991.3 473.5 370.0 141.9 92.5 34450.3 260.6 206.5 110.0 16668.1 12340.6 13100.0
8 340.6 51.4 0.0 802.5 343.6 2.5 386.3 83.6 5.0 46440.0 36473.6 58600.0
9 0.0 0.0 0.0 0.0 9.4 14.6 5.0 1831.3 186.5 10.0
10 36.9 31.5 10.0 4283.1 217.2 0.0 88583.1 10338.4 11577.5 36303.8 16651.7 21700.0
11 138855.6 293.0 195.0 13166.3 657.4 51312.5 323.8 172.9 167.5 18421.3 13427.8 14700.0
12 64060.0 689.9 5.0 19786.3 265.6 17.5 10748.8 548.8 795.0 167975.0 108179.3 165000.0
13 83828.1 5739.0 5.0 66.9 108.9 0.0 1.9 7.1 0.0 309127.5 6087.3 9880.0
14 21357.5 991.3 3065.0 18635.6 217.1 42.5 3.1 10.0 0.0 17991.9 3726.0 472.5
15 524.4 148.3 5.0 595.6 67.1 25.0 3.1 10.0 0.0 11368.6 1470.2 8695.0
16 0.0 0.0 4.3 30.0 0.0 10642.5 1072.7 1820.0 29298.6 5818.4 12800.0
17 0.0 0.0 0.0 0.0 3638.8 550.0 842.5 240960.8 83343.9 276000.0
18 42008.0 18822.7 23000.0 1012.5 374.6 2805.0 55.0 28.0 5.0 33958.3 7179.3 12550.0
19 80.0 640.0 0.0 18.8 13.1 7.5 1.4 10.0 0.0 4541.9 792.9 757.5
20 128262.5 278198.1 0.0 54519.4 54073.8 4527.5 762.5 731.8 0.0 29780.7 1267.2 2445.0
21 102764.4 6311.4 320.0 6687.9 742.5 175.0 129.4 79.9 32.5 93361.3 3297.5 7567.5
22 1915.0 110.5 7.5 8001.9 354.2 50.0 19973.8 6340.0 4885.0 57913.1 34616.6 50000.0
23 96601.3 4230.8 40.0 43156.9 1116.2 25.0 28.1 21.9 0.0 22013.1 2583.0 6232.5
24 0.0 0.0 0.7 5.0 0.0 886.3 126.6 7.5 22245.0 8182.9 17600.0
25 2117.1 270.5 10.0 1693.6 74.6 5.0 2784.3 517.2 190.0 256910.0 99538.7 221200.0
26 7186.9 1681.0 8715.0 10192.5 1482.7 47.5 9.4 18.7 0.0 225352.5 48547.0 27950.0
27 24008.8 12488.0 915.0 6543.1 2258.3 22107.5 999.4 696.2 225.0 200101.3 35781.5 32800.0
28 7295.0 374.3 15.0 260.8 69.5 15.0 24566.7 10982.1 8100.0 284233.3 240255.5 239500.0
29 85386.3 416.7 330870.0 16203.8 3131.5 52300.0 25531.4 17417.5 20400.0 103425.0 53751.7 40500.0
30 208383.1 84689.6 6100.0 171998.8 51253.1 27950.0 2828.8 783.1 697.5 27607.5 12939.1 25925.0
31 32433.8 2448.7 114242.5 106513.8 6197.6 702.5 6787.9 1829.5 897.5 77640.0 11681.4 23900.0
32 432.1 42.2 5.0 11560.6 74.8 5.0 11.3 12.0 10.0 7839.4 3298.0 5547.5
33 54625.0 11426.8 8172.5 42547.5 11990.0 17300.0 3573.8 1399.3 2097.5 141297.5 59903.4 91300.0
34 18411.9 1065.2 1370.0 8442.5 481.2 422.5 10470.0 249.4 85.0 27636.9 11697.0 9930.0
35 1.4 10.0 0.0 20.0 140.0 0.0 22897.1 1257.8 495.0 52500.7 9852.9 10100.0
36 6.9 18.2 0.0 4286.9 811.3 0.0 3581.3 220.7 112.5 163162.5 69687.7 84800.0
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in future studies.
Previous studies investigating the eﬀects of anticoccidials in sheep
have mostly compared diﬀerent drugs with respect to oocyst excretion,
faecal consistency, and weight gain without calculating the eﬃcacy of
the individual drugs (Gjerde et al., 2009; Le Sueur et al., 2009; Diaferia
et al., 2013). The classiﬁcation thresholds used in our study were based
on the ﬁgures of 90% and 95% used by Geurden et al. (2015) and Peña-
Espinoza et al. (2016) in anthelmintic studies, as there is currently no
published target eﬃcacy available for toltrazuril. The same classiﬁca-
tion targets were used by de Souza Rodrigues et al. (2017) who in-
vestigated the eﬃcacy of diﬀerent toltrazuril treatment strategies in
Brazil. However, we note that although these ﬁgures seem reasonable in
the absence of alternatives, there is no speciﬁc evidence to support the
direct translation of 90% and 95% eﬃcacy targets from their intended
context of estimating the arithmetic mean eﬃcacy of anthelmintic
compounds against nematodes to the quite diﬀerent context of esti-
mating the geometric mean eﬃcacy of anticoccidial compounds. The
lack of published target eﬃcacy was highlighted by Joachim et al.
(2018) as one of the main challenges evaluating ACE in farm animals,
and accentuate the importance of performing CETs in order to diagnose
ACR properly. Consequently, there is a need for additional research into
the expected geometric mean eﬃcacy of anticoccidial drugs in a ‘sus-
ceptible’ population, after which the currently used arbitrary thresholds
may be modiﬁed on the basis of evidence.
The Federation of Veterinarians of Europe has recently highlighted
the importance of coccidiostats being only available by veterinary
prescription (FVE, 2016), which is an important measure to control
their use, and thereby potentially extend their eﬃcacious period. By
applying the method described here, we were able to produce the ﬁrst
evidence-based description of reduced toltrazuril eﬃcacy against ovine
Eimeria spp., and to highlight the importance of ensuring that treatment
timing is appropriate. However, the validity of our results requires
conﬁrmation by CET. The present results suggest that the threat of
emerging ACR should be taken seriously in order to safeguard animal
welfare and future productivity of the sheep industry. Additional stu-
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